UBS Group’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976M | Sell |
2,405,949
-214,005
| -8% | -$86.8M | 0.17% | 85 |
|
|
2025
Q1 | $1.3B | Buy |
2,619,954
+189,283
| +8% | +$94.2M | 0.24% | 54 |
|
|
2024
Q4 | $1.26B | Sell |
2,430,671
-115,988
| -5% | -$60.3M | 0.23% | 59 |
|
|
2024
Q3 | $1.58B | Buy |
2,546,659
+50,816
| +2% | +$31.4M | 0.34% | 35 |
|
|
2024
Q2 | $1.38B | Buy |
2,495,843
+205,653
| +9% | +$114M | 0.34% | 38 |
|
|
2024
Q1 | $1.33B | Buy |
2,290,190
+191,876
| +9% | +$112M | 0.33% | 41 |
|
|
2023
Q4 | $1.11B | Buy |
2,098,314
+55,668
| +3% | +$29.5M | 0.33% | 41 |
|
|
2023
Q3 | $1.03B | Sell |
2,042,646
-65,347
| -3% | -$33.1M | 0.36% | 39 |
|
|
2023
Q2 | $1.1B | Buy |
2,107,993
+37,752
| +2% | +$19.7M | 0.37% | 38 |
|
|
2023
Q1 | $1.19B | Buy |
2,070,241
+187,629
| +10% | +$108M | 0.44% | 32 |
|
|
2022
Q4 | $1.04B | Buy |
1,882,612
+82,745
| +5% | +$45.6M | 0.39% | 40 |
|
|
2022
Q3 | $913M | Sell |
1,799,867
-115,382
| -6% | -$58.5M | 0.4% | 33 |
|
|
2022
Q2 | $1.04B | Sell |
1,915,249
-247,659
| -11% | -$135M | 0.43% | 28 |
|
|
2022
Q1 | $1.28B | Buy |
2,162,908
+41,987
| +2% | +$24.8M | 0.43% | 31 |
|
|
2021
Q4 | $1.42B | Sell |
2,120,921
-167,010
| -7% | -$111M | 0.41% | 27 |
|
|
2021
Q3 | $1.31B | Sell |
2,287,931
-10,592
| -0.5% | -$6.05M | 0.41% | 29 |
|
|
2021
Q2 | $1.16B | Sell |
2,298,523
-158,057
| -6% | -$79.7M | 0.37% | 37 |
|
|
2021
Q1 | $1.12B | Sell |
2,456,580
-264,486
| -10% | -$121M | 0.37% | 33 |
|
|
2020
Q4 | $1.27B | Buy |
2,721,066
+77,644
| +3% | +$36.2M | 0.43% | 27 |
|
|
2020
Q3 | $1.17B | Sell |
2,643,422
-189,620
| -7% | -$83.7M | 0.44% | 31 |
|
|
2020
Q2 | $1.03B | Sell |
2,833,042
-226,106
| -7% | -$81.9M | 0.43% | 36 |
|
|
2020
Q1 | $868M | Sell |
3,059,148
-317,285
| -9% | -$90M | 0.41% | 42 |
|
|
2019
Q4 | $1.1B | Buy |
3,376,433
+39,759
| +1% | +$12.9M | 0.38% | 44 |
|
|
2019
Q3 | $972M | Sell |
3,336,674
-170,464
| -5% | -$49.7M | 0.37% | 43 |
|
|
2019
Q2 | $1.03B | Buy |
3,507,138
+240,526
| +7% | +$70.6M | 0.4% | 41 |
|
|
2019
Q1 | $894M | Sell |
3,266,612
-76,006
| -2% | -$20.8M | 0.37% | 46 |
|
|
2018
Q4 | $748M | Buy |
3,342,618
+163,089
| +5% | +$36.5M | 0.34% | 51 |
|
|
2018
Q3 | $776M | Buy |
3,179,529
+98,989
| +3% | +$24.2M | 0.31% | 53 |
|
|
2018
Q2 | $638M | Buy |
3,080,540
+70,574
| +2% | +$14.6M | 0.28% | 64 |
|
|
2018
Q1 | $621M | Buy |
3,009,966
+12,780
| +0.4% | +$2.64M | 0.27% | 69 |
|
|
2017
Q4 | $569M | Buy |
2,997,186
+11,011
| +0.4% | +$2.09M | 0.23% | 78 |
|
|
2017
Q3 | $565M | Sell |
2,986,175
-26,191
| -0.9% | -$4.96M | 0.26% | 72 |
|
|
2017
Q2 | $526M | Buy |
3,012,366
+53,592
| +2% | +$9.35M | 0.27% | 70 |
|
|
2017
Q1 | $454M | Buy |
2,958,774
+53,311
| +2% | +$8.19M | 0.25% | 75 |
|
|
2016
Q4 | $410M | Buy |
2,905,463
+141,143
| +5% | +$19.9M | 0.23% | 85 |
|
|
2016
Q3 | $440M | Buy |
2,764,320
+128,683
| +5% | +$20.5M | 0.26% | 62 |
|
|
2016
Q2 | $389M | Buy |
2,635,637
+122,327
| +5% | +$18.1M | 0.24% | 73 |
|
|
2016
Q1 | $356M | Buy |
2,513,310
+5,844
| +0.2% | +$827K | 0.24% | 74 |
|
|
2015
Q4 | $356M | Buy |
2,507,466
+376,962
| +18% | +$53.5M | 0.23% | 79 |
|
|
2015
Q3 | $261M | Buy |
2,130,504
+191,170
| +10% | +$23.4M | 0.18% | 111 |
|
|
2015
Q2 | $252M | Buy |
1,939,334
+369,693
| +24% | +$48M | 0.17% | 130 |
|
|
2015
Q1 | $211M | Buy |
1,569,641
+516,568
| +49% | +$69.4M | 0.15% | 145 |
|
|
2014
Q4 | $132M | Buy |
+1,053,073
| New | +$132M | 0.09% | 198 |
|